source
- Novo Nordisk seeks injunction to halt Eli Lilly's obesity drug adsNovo Nordisk filed a motion in a New Jersey federal court asking for a preliminary injunction that would stop Eli Lilly's advertisements for its obesity treatments. Novo claims the ads are mislead…
- FDA issues early alert on Boston Scientific ENROUTE catheter tip separation riskThe CDRH has issued an Early Alert warning about a potential high risk issue with Boston Scientific's ENROUTE Transcarotid Neuroprotection System and its Plus version. The problem involves possibl…